Rule 901:14-2-17 | Labeling.
(A) All hemp-derived cannabinoid products shall be labeled:
(1) In accordance with the following standards:
(a) The labeling requirements found in rule 901:3-1-11 of the Administrative Code.
(b) The standard of identity requirements found in rule 901:3-1-12 of the Administrative Code.
(c) The food coloring requirements found in rule 901:3-1-13 of the Administrative Code.
(d) The total tetrahydrocannabinol (TTHC) in milligrams as outlined in paragraph (M)(4)(c) of rule 901:14-2-01 of the Administrative Code.
(2) With the milligrams per serving for all cannabinoids as identified on the product label, if the hemp-derived cannabinoid product meets the definitions of either a food or dietary supplement as found in rule 901:14-2-01 of the Administrative Code.
(3) With the total milligrams per unit for all cannabinoids as identified on the product label, if the hemp-derived cannabinoid product meets the definitions of a cosmetic product as found in rule 901:14-2-01 of the Administrative Code.
(4) With the cannabinoid profile of the product that matches the laboratory reporting for each unique batch or lot as required in paragraph (A)(9) of rule 901:14-2-15 of the Administrative Code, if the hemp-derived cannabinoid product does not meet the definition of food, dietary supplement, or cosmetic products as found in rule 901:14-2-01 of the Administrative Code.
(5) With the unique batch or lot coding that will match the hemp-derived cannabinoid product with a batch or lot, in order to facilitate any warnings or recalls the department deems appropriate.
(a) Each container or product shall be marked with an identifying code permanently visible to the naked eye.
(b) The required identification shall specify in code the establishment where the product was packed, the product contained therein, and the year, day, and period during which it was packed.
(c) The packing period code shall be changed often enough to enable ready identification of lots during their sale and distribution.
(d) Codes may be changed periodically on one of the following bases:
(i) Intervals of four to five hours;
(ii) Personnel shift changes; or
(iii) Batches, as long as the containers constituting the batch do not represent those processed during more than one personnel shift.
(6) With a statement, if the products contain cannabinoids, indicating that consumers should consult a licensed healthcare professional if pregnant, breast feeding, currently taking medications, or under eighteen years of age.
This statement shall appear prominently and conspicuously as compared to other words, statements, or designs on the information panel of the immediate container label, but in no case may the letters be less than one-sixteenth inch in height. Where the immediate container is not the retail package, this warning statement shall also appear prominently and conspicuously on the information panel of the retail package label.
This requirement does not apply to products derived exclusively from hemp seed oil.
(B) Hemp-derived cannabinoid product labeling requirements by classification:
(1) All hemp-derived cannabinoid products which meet the definition of a food as found in rule 901:14-2-01 of the Administrative Code shall meet the labeling requirements in 21 C.F.R. 101.9 (2025 edition).
(2) All hemp-derived cannabinoid products which meet the definition of a dietary supplement as found in rule 901:14-2-01 of the Administrative Code shall meet the labeling requirements in 21 C.F.R. 101.36 (2025 edition).
(3) All cosmetic products shall be labeled in accordance with 21 C.F.R. Part 701 (2024 edition) and 21 C.F.R. 740 (2024 edition) as applicable.
Last updated November 9, 2026 at 12:00 AM
Supplemental Information